Pharma News

Boehringer Ingelheim and Zealand Pharma A/S announced that the US Food and Drug Administration has granted Fast Track Designation to the GLP-1/glucagon dual agonist BI 456906 for adults with non-alcoholic steatohepatitis . The Fast Track Designation facilitates the development and expedites the review of new therapies to treat serious conditions and fill an unmet medical need. BI 456906 is currently being evaluated in a Phase II study in adults with NASH and liver fibrosis (F2/F3) with and without diabetes.

It is 2019 when Prof. Saptarshi Majumdar & Dr. Chandra Shekhar Sharma from the Department of Chemical Engineering has made a proven study about oral nanofibrous AMB to be effective for Kala Azar. This is a first-ever attempt to fabricate nanofibrous oral tablets of Amphotericin B for the potential cure of Leishmaniasis or Kala Azar. With the 2 years of advancement of examination, the researchers are now confident that the technology can be transferred to suitable pharma partners for large-scale production.

Indian Institute of Technology, Ropar in Punjab has developed a first-of-its-kind IoT device AmbiTag that records real-time ambient temperature during the transportation of perishable products, vaccines and even body organs and blood. That recorded temperature further helps to know whether that particular item transported from anywhere in the world is still usable or perished because of temperature variation. This information is particularly critical for vaccines including Covid-19 vaccine, organs and blood transportation.

Researchers world-wide are focused on clearing the toxic mutant Huntingtin protein that leads to neuronal cell death and systemic dysfunction in Huntingtons disease (HD), a devastating, incurable, progressive neurodegenerative genetic disorder. Scientists in the Buck Institutes Ellerby lab have found that the targeting the protein called FK506-binding protein 51 or FKBP51 promotes the clearing of those toxic proteins via autophagy, a natural process whereby cells recycle damaged proteins and mitochondria and use them for nutrition.

Army scientists working as part of an international consortium have developed and tested an antibody-based therapy to treat Crimean-Congo hemorrhagic fever virus (CCHFV), which is carried by ticks and kills up to 60 percent of those infected. Their results are published online today in the journal Cell.

Scientists have fabricated a device that can mimic human brain cognitive actions and is more efficient than conventional techniques in emulating artificial intelligence, thus enhancing the computational speed and power consumption efficiency.

A study in 5.8 million children has found a higher incidence of stroke four decades later in those whose mother had high blood pressure or pre-eclampsia while pregnant. The research is presented at ESC Heart & Stroke 2021, an online scientific conference of the European Society of Cardiology (ESC).

The COVID-19 Vaccine Janssen has been given regulatory approval by the Medicines and Healthcare products Regulatory Agency . This is the fourth COVID-19 vaccine to be authorised by the UKs independent regulator and is the first to be approved for protection against COVID-19 with a single dose.

Bal Pharma Ltd is pleased to announce the launch of Favipiravir formulation into Indian market, under the brand name BALflu.